Pharmaceutical Online Videos

  1. Bora Pharmaceuticals Capacity Update April 2025: Fill/Finish 4/25/2025

    Tara Lorenz, Sr. Director of Commercial Operations, speaks on our latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics, and other sterile injectable products.

  2. Simtra Biopharma Solutions Capacity Update April 2025: Fill/Finish 4/25/2025

    With expertise in process optimization, analytics, and regulatory strategy, we help partners de-risk development, accelerate time to market, and ensure manufacturability from the outset.

  3. Mabion Capacity Update April 2025: Fill/Finish 4/25/2025

    Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.

  4. Resilience Capacity Update April 2025: Fill/Finish 4/25/2025

    In this update, you will hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support manufacturing programs from clinical through commercial.

  5. Curia Capacity Update April 2025: Fill/Finish 4/25/2025

    Discover how proven sterile fill-finish expertise, high-potency capabilities, and customizable cleanrooms can support your product from development to commercialization.

  6. IDT Biologika Capacity Update April 2025: Fill/Finish 4/25/2025

    Watch as Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights IDT Biologika´s overall fill-finish capabilities and capacities, with a focus on our ability to help meet your complex needs.

  7. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish 4/25/2025

    Executive Director of Technology and Business Development for Drug Product and Finished Goods, Henrik Herrmann, shares an update on the current and future state of FDB’s capabilities.

  8. Argonaut Capacity Update April 2025: Fill/Finish 4/25/2025

    Advance your clinical and commercial programs with expert aseptic fill finish and formulation services across vials, cartridges, and syringes, all in state-of-the-art, EU Annex 1-compliant facilities.

  9. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Director of Commercial Development, Serat Ali, describes FDBs' Advanced Therapy capabilities, discusses their global facilities network, and provides a capacity update.

  10. Cambrex Capacity Update April 2025: Small Molecule 4/23/2025

    Chief Scientific Officer of Cambrex and President of Snapdragon Chemistry, Matthew Bio, Ph.D., presents the company’s capabilities in the development of peptide therapeutics.